Why the study?
The characteristics of heart risk variability in patients with non-alcoholic fatty liver disease (NAFLD) were not well defined.
Observational (n=103)
Patients with NAFLD and type 2 diabetes exhibit reduced heart rate variability and worse lipid profiles compared to healthy controls, suggesting increased autonomic dysfunction and cardiovascular risk.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Мосина et al. (2019) conducted an observational in Non-alcoholic fatty liver disease (n=103). Non-alcoholic fatty liver disease and type 2 diabetes vs. Healthy patients was evaluated on Heart rate variability (SDNN and SDNNidx).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: